<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Onsior gets new chronic pain indication in cats</title><link>/b/veterinary-nursing-news/posts/onsior-gets-new-chronic-pain-indication-in-cats</link><description> Elanco has announced that Onsior 6 mg tablets have been licensed for the treatment of pain and inflammation associated with chronic musculoskeletal disorders in cats. 
 The NSAID&amp;#39;s new indication is in addition to its existing license for acute pain</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>